Iacob, Speranta <br/><br/>
100% sustained virological response and fibrosis improvement in real-life use of direct acting antivirals in genotype-1b recurrent hepatitis C following liver transplantation.  [electronic resource] 

 -  Journal of gastrointestinal and liver diseases : JGLD  Jun 2018 
 - 139-144 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1842-1121 
<br/><br/><label>Standard No.: </label>10.15403/jgld.2014.1121.272.100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adult<br/>Aged<br/>Anilides--adverse effects<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Carbamates--adverse effects<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--adverse effects<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Lactams, Macrocyclic<br/>Liver Cirrhosis--virology<br/>Liver Transplantation<br/>Macrocyclic Compounds--adverse effects<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Ribavirin--adverse effects<br/>Ritonavir--adverse effects<br/>Sofosbuvir<br/>Sulfonamides--adverse effects<br/>Sustained Virologic Response<br/>Uracil--adverse effects<br/>Uridine Monophosphate--adverse effects<br/>Valine